tno155
Showing 1 - 9 of 9
Renal Impairment Trial (TNO155)
Not yet recruiting
- Renal Impairment
- TNO155
- (no location specified)
Sep 16, 2022
Hepatic Impairment Trial (TNO155)
Not yet recruiting
- Hepatic Impairment
- TNO155
- (no location specified)
Aug 4, 2022
Non-small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal SCC Trial in Worldwide (TNO155, Spartalizumab,
Recruiting
- Non-small Cell Lung Carcinoma
- +4 more
- TNO155
- +2 more
-
Boston, Massachusetts
- +8 more
Mar 18, 2022
Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in United States (MRTX849, TNO155)
Active, not recruiting
- Advanced Cancer
- +2 more
- MRTX849
- TNO155
-
Los Angeles, California
- +11 more
Nov 12, 2021
BRAF V600 Colorectal Cancer Trial in Worldwide (Dabrafenib, LTT462, Trametinib)
Recruiting
- BRAF V600 Colorectal Cancer
- Dabrafenib
- +6 more
-
Los Angeles, California
- +17 more
Jun 7, 2022
KRAS G12C Mutant Solid Tumors, NSCLC, Carcinoma, Colorectal Trial in Worldwide (JDQ443, TNO155, tislelizumab)
Recruiting
- KRAS G12C Mutant Solid Tumors
- +9 more
- JDQ443
- +2 more
-
Atlanta, Georgia
- +31 more
Jul 7, 2022
NSCLC, Colorectal Neoplams, Endometrial Tumors Trial in Worldwide (LY3537982, Abemaciclib, Erlotinib)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +4 more
- LY3537982
- +7 more
-
Los Angeles, California
- +21 more
Jul 22, 2022
Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)
Recruiting
- Advanced Solid Tumors
- Kirsten Rat Sarcoma (KRAS) pG12C Mutation
- Sotorasib
- +15 more
-
Tucson, Arizona
- +83 more
Dec 28, 2022